Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Gerstoft

Showing results (231-240 of 306) with videos related to

Pageof 31
Sort By:
Ugeskrift for Laeger|September 10, 2019
[Management of Staphylococcus aureus bacteraemia]Louise Thorlacius-Ussing, Nis Pedersen Jørgensen, Jesper Smit, et al.
Scandinavian Journal of Infectious Diseases|June 17, 2004
Tenofovir treatment in an unselected cohort of highly antiretroviral experienced HIV positive patientsAnne Lerbaek, Thomas B Kristiansen, Terese L Katzenstein, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 23, 2018
Higher Risk of Abdominal Obesity, Elevated Low-Density Lipoprotein Cholesterol, and Hypertriglyceridemia, but not of Hypertension, in People Living With Human Immunodeficiency Virus (HIV): Results From the Copenhagen Comorbidity in HIV Infection StudyMarco Gelpi, Shoaib Afzal, Jens Lundgren, et al.
AIDS (London, England)|January 24, 2014
The origin and emergence of an HIV-1 epidemic: from introduction to endemicityChristian A W Bruhn, Anne M Audelin, Marie Helleberg, et al.
AIDS (London, England)|June 17, 2009
Induction of novel CD8+ T-cell responses during chronic untreated HIV-1 infection by immunization with subdominant cytotoxic T-lymphocyte epitopesHenrik Kloverpris, Ingrid Karlsson, Jesper Bonde, et al.
HIV Medicine|May 6, 2022
Potential drug-drug interactions between antiretroviral drugs and comedications, including dietary supplements, among people living with HIV: A clinical surveyMichaela Tinggaard, Kim Peter David, Jan Gerstoft, et al.
Frontiers in Immunology|May 3, 2021
Independent Associations of Tumor Necrosis Factor-Alpha and Interleukin-1 Beta With Radiographic Emphysema in People Living With HIVRebekka F Thudium, Hedda Ringheim, Andreas Ronit, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 20, 2006
Ritonavir-boosted tipranavir demonstrates superior efficacy to ritonavir-boosted protease inhibitors in treatment-experienced HIV-infected patients: 24-week results of the RESIST-2 trialPedro Cahn, Jorge Villacian, Adriano Lazzarin, et al.
International Journal of Molecular Sciences|February 5, 2015
Genetic variants in the apoptosis gene BCL2L1 improve response to interferon-based treatment of hepatitis C virus genotype 3 infectionLouise Nygaard Clausen, Nina Weis, Steen Ladelund, et al.
Frontiers in Immunology|October 29, 2020
Impact of Age and HIV Status on Immune Activation, Senescence and ApoptosisMalene Hove-Skovsgaard, Yanan Zhao, Jeanette Linnea Tingstedt, et al.
Pageof 31

Showing results (231-240 of 306) with videos related to

Sort By:
Pageof 31
Ugeskrift for Laeger|September 10, 2019
[Management of Staphylococcus aureus bacteraemia]Louise Thorlacius-Ussing, Nis Pedersen Jørgensen, Jesper Smit, et al.
Scandinavian Journal of Infectious Diseases|June 17, 2004
Tenofovir treatment in an unselected cohort of highly antiretroviral experienced HIV positive patientsAnne Lerbaek, Thomas B Kristiansen, Terese L Katzenstein, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 23, 2018
Higher Risk of Abdominal Obesity, Elevated Low-Density Lipoprotein Cholesterol, and Hypertriglyceridemia, but not of Hypertension, in People Living With Human Immunodeficiency Virus (HIV): Results From the Copenhagen Comorbidity in HIV Infection StudyMarco Gelpi, Shoaib Afzal, Jens Lundgren, et al.
AIDS (London, England)|January 24, 2014
The origin and emergence of an HIV-1 epidemic: from introduction to endemicityChristian A W Bruhn, Anne M Audelin, Marie Helleberg, et al.
AIDS (London, England)|June 17, 2009
Induction of novel CD8+ T-cell responses during chronic untreated HIV-1 infection by immunization with subdominant cytotoxic T-lymphocyte epitopesHenrik Kloverpris, Ingrid Karlsson, Jesper Bonde, et al.
HIV Medicine|May 6, 2022
Potential drug-drug interactions between antiretroviral drugs and comedications, including dietary supplements, among people living with HIV: A clinical surveyMichaela Tinggaard, Kim Peter David, Jan Gerstoft, et al.
Frontiers in Immunology|May 3, 2021
Independent Associations of Tumor Necrosis Factor-Alpha and Interleukin-1 Beta With Radiographic Emphysema in People Living With HIVRebekka F Thudium, Hedda Ringheim, Andreas Ronit, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 20, 2006
Ritonavir-boosted tipranavir demonstrates superior efficacy to ritonavir-boosted protease inhibitors in treatment-experienced HIV-infected patients: 24-week results of the RESIST-2 trialPedro Cahn, Jorge Villacian, Adriano Lazzarin, et al.
International Journal of Molecular Sciences|February 5, 2015
Genetic variants in the apoptosis gene BCL2L1 improve response to interferon-based treatment of hepatitis C virus genotype 3 infectionLouise Nygaard Clausen, Nina Weis, Steen Ladelund, et al.
Frontiers in Immunology|October 29, 2020
Impact of Age and HIV Status on Immune Activation, Senescence and ApoptosisMalene Hove-Skovsgaard, Yanan Zhao, Jeanette Linnea Tingstedt, et al.
Pageof 31